Based on recent data, RAPT Therapeutics, Inc. (RAPT) shows an Average True Range (ATR) of 3.79 and an Enterprise Value of 234.33M. Its average trading volume over the past 3 months is 967.3K, indicating liquidity. These fundamental metrics provide insight into RAPT's underlying financial health and market activity.
| ATR | 3.79 |
| Enterprise Value | 234.33M |
| Avg Vol (3 Months) | 967.3K |
| Avg Vol (10 Days) | 8.13M |
RAPT Therapeutics, Inc. (RAPT) technical indicators as of January 21, 2026: the SMA 20 is 65%, SMA 50 at 75.06%, and SMA 200 at 211.43%. The RSI 14 value is 80.09, suggesting its current momentum. These technical analysis signals help assess RAPT's price trends and potential future movements.
| SMA 20 | 65% |
| SMA 50 | 75.06% |
| SMA 200 | 211.43% |
| RSI 14 | 80.09 |
RAPT Therapeutics, Inc. (RAPT) stock performance overview as of January 21, 2026: The 52-week high is $57.61 (currently 35.8% below), and the 52-week low is $5.665 (currently 916.2% above). Over the past year, RAPT's performance is 504.73%, compared to the S&P 500's 9.18% change.
| 52-Week High | 57.61 |
| 52-Week High Chg | +35.80% |
| 52-Week Low | 5.665 |
| 52-Week Low Chg | +916.20% |
| S&P 500 52-Week Chg | 9.18% |
According to market data, RAPT Therapeutics, Inc. (RAPT) stock's recent performance metrics show that over the last month, RAPT is 73.51%, with a Year-to-Date (YTD) performance of 69.97%. Over the past year, the stock has seen a 504.73% change. These figures summarize RAPT's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 57.61 | 57.61 | 57.61 | 57.61 | 57.61 | 57.61 |
| Low | 32 | 29.77 | 25.5 | 8.75 | 5.665 | 29.77 |
| Performance | +67.35% | +73.51% | +96.22% | +392.05% | +504.73% | +69.97% |
According to current financial data, RAPT stock's P/E (TTM) ratio is -14.69, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for RAPT, including P/S (N/A), P/B (10.21), and P/FCF (-10.98), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | RAPT | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -14.69 | -1.23 | -5.15 | 32.59 |
| P/S (TTM) | N/A | 3.71 | 465.3 | 5.98 |
| P/B (TTM) | 10.21 | -0.33 | 9.35 | 5.66 |
| P/FCF (TTM) | -10.98 | -21.39 | -348.58 | 33.18 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep